Febuxostat Tablets 10mg (Febuxostat “DSEP”® / フェブキソスタット錠10mg「DSEP」)

JPY ¥1,000

Japanese non-purine selective xanthine oxidase inhibitor (Febuxostat 10mg). Oral tablet for treatment of gout and hyperuricemia. 100 tablets (10 tablets x 10). Mfd. by Daiichi Sankyo Espha Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥920
10 - 19 12% JPY ¥880
20 + 18% JPY ¥820
SKU: FEB-10-TAB Category:

Description

Product Overview / 商品概要

Febuxostat Tablets 10mg “DSEP” (フェブキソスタット錠10mg「DSEP」)
Generic: Febuxostat / フェブキソスタット
Therapeutic Category: Non-purine selective xanthine oxidase inhibitor / Hyperuricemia treatment agent / 非プリン型選択的キサンチンオキシダーゼ阻害剤・高尿酸血症治療剤
Manufactured by: Daiichi Sankyo Espha Co., Ltd. / 第一三共エスファ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Febuxostat (JP) 10mg per tablet / 1錠中 フェブキソスタット(日局)10mg
Additives: Lactose, Partially pregelatinized starch, Hydroxypropylcellulose, Croscarmellose sodium, Magnesium stearate, Hypromellose, Macrogol / 乳糖、部分アルファー化デンプン、ヒドロキシプロピルセルロース、クロスカルメロースナトリウム、ステアリン酸マグネシウム、ヒプロメロース、マクロゴール
Appearance: White to slightly yellowish film-coated tablet; diameter approx. 7mm, thickness approx. 3mm, weight approx. 132mg
外観: 白色~微黄色のフィルムコーティング錠、直径約7mm、厚さ約3mm、重さ約132mg

Indications / 効能効果

EN: Gout and hyperuricemia / Hyperuricemia associated with cancer chemotherapy
JA: 痛風、高尿酸血症/がん化学療法に伴う高尿酸血症

Dosage and Administration / 用法用量

EN: Usually, adults start with 10mg of febuxostat once daily orally. The dose is then gradually increased as necessary while monitoring serum uric acid levels. The maintenance dose is usually 40mg once daily, adjusted according to the patient’s condition, with a maximum dose of 60mg once daily. Usually, adults receive 60mg of febuxostat once daily orally.
JA: 〈痛風、高尿酸血症〉通常、成人にはフェブキソスタットとして1日10mgより開始し、1日1回経口投与する。その後は血中尿酸値を確認しながら必要に応じて徐々に増量する。維持量は通常1日1回40mgで、患者の状態に応じて適宜増減するが、最大投与量は1日1回60mgとする。〈がん化学療法に伴う高尿酸血症〉通常、成人にはフェブキソスタットとして60mgを1日1回経口投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product / Patients receiving mercaptopurine hydrate or azathioprine
JA: 本剤の成分に対し過敏症の既往歴のある患者/メルカプトプリン水和物又はアザチオプリンを投与中の患者

Regulatory Information / 規制情報

Approval No.: 30400AMX00100
Sales Started: June 2022 / 2022年6月
Classification Code: 873949
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets (10 tablets x 10) / 100錠(10錠×10)
Other Available Packages (by special order): PTP blister: 100 tablets (10 tablets x 10), 500 tablets (10 tablets x 50) / Plastic bottle (bulk): 500 tablets

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Febuxostat Tablets 10mg (Febuxostat “DSEP”® / フェブキソスタット錠10mg「DSEP」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Febuxostat Tablets 10mg (Febuxostat "DSEP"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.